The molecular mechanism by which gadophrin-2 targets necrotic tumor tissue
was investigated. Biodistribution studies and magnetic resonance imaging (M
RI) and histologic/autoradiographic correlation were performed in xenograft
mouse models bearing human tumors (HT 29, WiDr. LX 1), Binding of gadophri
n-2 to DNA, lipids, or proteins was determined by fluorescence spectrophoto
metry, Protein binding was determined by dialysis and gel electrophoresis.
Accumulation of gadophrin-2 was low (<0.7% injected dose/g tissue at 24 hou
rs after injection) in viable tumor but higher in necrotic tumor regions an
d was readily detectable by MRI, Within a given tumor, the agent preferenti
ally localized in the periphery of necrotic areas. Within these regions gad
ophrin-2 was bound to interstitial albumin and not other proteins, lipids,
or DNA. Tumoral accumulation of gadophrin-2 most likely occurs through its
binding to plasma albumin and subsequent slow extravasation into the tumor
interstitium. J. Magn. Reson. Imaging 1999:9:336-341, (C) 1999 Wiley-Liss,
Inc.